Cargando…
Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications
Traditionally, guidelines divide patients into primary and secondary prevention for atherosclerotic cardiovascular disease (ASCVD) risk management. However, the modern understanding of the biological progression of atherosclerosis is inconsistent with this binary approach. Therefore, a new approach...
Autores principales: | Blaha, Michael J., Abdelhamid, Magdy, Santilli, Francesca, Shi, Zhongwei, Sibbing, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826921/ https://www.ncbi.nlm.nih.gov/pubmed/36632617 http://dx.doi.org/10.1016/j.ajpc.2022.100456 |
Ejemplares similares
-
Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
por: Li, Xiao-Ying, et al.
Publicado: (2022) -
Secondhand Smoke Exposure and Subclinical Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Jones, Miranda R., et al.
Publicado: (2016) -
Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019) -
Endothelial dysfunction and the risk of atherosclerosis in overt and subclinical hypothyroidism
por: Saif, Aasem, et al.
Publicado: (2018) -
Subclinical hypothyroidism in children: is it always subclinical?
por: Gallizzi, R., et al.
Publicado: (2018)